Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06390982
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-30
First Post:
2024-04-26
Brief Title:
Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer RELIEVE -01 Study
Sponsor:
Fudan University
Organization:
Fudan University
Organization Data
Organization:
Fudan University
Class:
OTHER
Study ID:
BGB-A317-2011-IIT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fudan University
Lead Sponsor Class:
OTHER
Responsible Party:
Xu jianmin
Responsible Party Title:
Chief Physician
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shanghai Zhongshan Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Liaoning Cancer Hospital Institute | OTHER |
| Shanghai Zhongshan Hospital | OTHER |
| Shanghai Changzheng Hospital | OTHER |
| Huadong Hospital | OTHER |
| RenJi Hospital | OTHER |
| The Fourth Hospital of Hebei Medical University | UNKNOWN |
| First Hospital of China Medical University | OTHER |